Syngene International Limited Share Price
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 433.15 INR | +0.06% |
|
-4.34% | -33.46% |
| 11:27am | Syngene International Ltd says partial relief granted to company in tax appeals | RE |
| 02-06 | Excelsoft Technologies Limited Announces Executive Changes | CI |
| Capitalization | 172B 1.9B 1.61B 1.47B 1.41B 2.6B 2.69B 17.13B 6.79B 83.17B 7.13B 6.99B 292B | P/E ratio 2026 * |
60.2x | P/E ratio 2027 * | 37.5x |
|---|---|---|---|---|---|
| Enterprise value | 160B 1.76B 1.49B 1.36B 1.3B 2.41B 2.5B 15.89B 6.29B 77.15B 6.62B 6.48B 271B | EV / Sales 2026 * |
4.33x | EV / Sales 2027 * | 3.73x |
| Free-Float |
44.57% | Yield 2026 * |
0.23% | Yield 2027 * | 0.31% |
Last Transcript: Syngene International Limited
| 1 day | +0.06% | ||
| 1 week | -4.34% | ||
| Current month | -8.51% | ||
| 1 month | -30.93% | ||
| 3 months | -33.58% | ||
| 6 months | -35.12% | ||
| Current year | -33.46% |
| 1 week | 426.5 |  | 457.3 |
| 1 month | 426.5 | | 628.75 |
| Current year | 426.5 | | 678.95 |
| 1 year | 426.5 | | 760 |
| 3 years | 426.5 | | 960.6 |
| 5 years | 426.5 | | 960.6 |
| 10 years | 174.5 | | 960.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Bains
CEO | Chief Executive Officer | 67 | 14/02/2015 |
Yogesh Chethan
CMP | Compliance Officer | - | 22/07/2025 |
Jayashree Aiyar
CTO | Chief Tech/Sci/R&D Officer | - | 22/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 31/03/2020 | |
| Director/Board Member | 64 | 07/08/2000 | |
Paul Blackburn
BRD | Director/Board Member | 72 | 25/08/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | -4.34% | -38.20% | -23.67% | 1.9B | |
| -0.02% | +5.88% | -8.34% | -4.82% | 48.77B | |
| +0.09% | +1.40% | +49.59% | +55.53% | 39.27B | |
| -0.21% | +4.62% | +36.37% | +68.00% | 36.05B | |
| +1.94% | -5.66% | -13.46% | -21.51% | 27.89B | |
| -0.36% | +1.72% | +140.35% | +298.22% | 19.45B | |
| +2.09% | +21.07% | +33,113.55% | +4,734.13% | 15.61B | |
| +2.48% | +4.67% | +37.25% | -2.28% | 13.78B | |
| +1.24% | +2.03% | +44.69% | +101.21% | 13.71B | |
| +1.50% | -1.93% | +158.90% | +116.37% | 13.18B | |
| Average | +0.89% | +1.06% | +3,352.07% | +532.12% | 22.96B | |
| Weighted average by Cap. | +0.64% | +1.49% | +2,287.72% | +376.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.9B 407M 344M 314M 301M 556M 576M 3.67B 1.45B 17.8B 1.53B 1.5B 62.54B | 41.99B 463M 392M 358M 342M 633M 656M 4.17B 1.65B 20.25B 1.74B 1.7B 71.16B |
| Net income | 2.81B 30.95M 26.17M 23.9M 22.88M 42.27M 43.82M 279M 110M 1.35B 116M 114M 4.75B | 4.29B 47.28M 39.97M 36.51M 34.95M 64.56M 66.93M 426M 169M 2.07B 177M 174M 7.26B |
| Net Debt | -12.49B -138M -116M -106M -102M -188M -195M -1.24B -491M -6.02B -517M -506M -21.16B | -15.65B -173M -146M -133M -128M -236M -244M -1.55B -616M -7.55B -647M -634M -26.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/02/26 | 433.15 ₹ | +0.06% | 1,839,096 |
| 17/02/26 | 432.90 ₹ | -0.49% | 721,200 |
| 16/02/26 | 435.05 ₹ | +0.16% | 853,243 |
| 13/02/26 | 434.35 ₹ | -2.69% | 1,227,781 |
| 12/02/26 | 446.35 ₹ | -1.92% | 1,271,668 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SYNGENE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition